Description

Imidazo[4,5-E][1,4]Diazepin-8(3H)-One, 4,5,6,7-Tetrahydro-4,7-Dimethyl-5-Thioxo- is a high-purity, heterocyclic organic compound featuring a fused imidazole-diazepine core structure, which is of significant interest in advanced pharmaceutical research and development. This compound serves as a critical synthetic intermediate or a potential pharmacophore for designing novel therapeutic agents, particularly in the fields of oncology and central nervous system (CNS) disorders. It is primarily sought by R&D chemists, process development scientists, and manufacturers in the pharmaceutical, biotechnology, and fine chemical sectors.

Application

• Pharmaceutical Intermediate: A key building block for the synthesis of novel drug candidates targeting specific biological pathways.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization programs due to its unique fused-ring scaffold.
• Chemical Biology Probes: Serves as a core structure for developing tool compounds to study enzyme function or protein-protein interactions.
• Process Chemistry Development: Utilized in scaling up synthetic routes for potential active pharmaceutical ingredients (APIs).
• Academic Research: Employed in universities and research institutes for investigating new heterocyclic chemistry and reaction methodologies.
• Custom Synthesis & Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for client-specific synthesis projects.

Basic Information

Product Name	Imidazo[4,5-E][1,4]Diazepin-8(3H)-One, 4,5,6,7-Tetrahydro-4,7-Dimethyl-5-Thioxo-
CAS No.	959006-96-3
Molecular Formula	C9H11N3OS
Molecular Weight	209.27 g/mol
Synonyms	4,5,6,7-Tetrahydro-4,7-dimethyl-5-thioxo-3H-imidazo[4,5-e][1,4]diazepin-8-one; 3H-Imidazo[4,5-e][1,4]diazepin-8-one, 4,5,6,7-tetrahydro-4,7-dimethyl-5-thioxo-; 4,7-Dimethyl-5-thioxo-4,5,6,7-tetrahydro-3H-imidazo[4,5-e][1,4]diazepin-8-one; 959006-96-3; AI3-52362; CTK8G0666; ZINC000103029557; AKOS040757393; AS-80539; SCHEMBL23346877.
EINECS	Contact for details

Quality Control

Our Imidazo[4,5-E][1,4]Diazepin-8(3H)-One, 4,5,6,7-Tetrahydro-4,7-Dimethyl-5-Thioxo- is manufactured under a strict quality management system. Every batch undergoes comprehensive analytical testing, including HPLC for purity, NMR and IR for structural confirmation, and residual solvent analysis, to ensure it meets the high standards required for research and development. A detailed Certificate of Analysis (COA) is provided with each shipment, guaranteeing traceability, batch-to-batch consistency, and compliance with your specifications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider inert atmosphere conditions to maintain stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Loss on Drying	≤ 1.0%
Residue on Ignition	≤ 0.5%
Single Unknown Impurity (HPLC)	≤ 1.0%
Total Impurities (HPLC)	≤ 3.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.